HumanBioMonitoring-Schoeters - BioDetection Systems

More documents

Recommendations

Info

Evaluating time trendsMean lipid-adjusted TCDD levels in studies of general population groups inthe U.S., Canada, Germany, and France as a function of sampling year(Hays et al, Reg Tox Appl Pharm, 2007)
Evaluating spatial trendsVan Leeuwen FXR, Malisch R. Results of the third round of theWHO-coordinated exposure study on the levels of PCBs, PCDDs and PCDFs in human milk.Organohalogen Compounds, 2002, 56:311–316
Page 2 and 3: Outline• An introduction to human
Page 4 and 5: The causal chain:from exposure to e
Page 6 and 7: A brief introduction to HBMspecific
Page 8 and 9: A brief introduction to HBM• Envi
Page 12 and 13: Relation with health effects
Page 14 and 15: o evaluate the efficacity of policy
Page 16 and 17: European initiatives humanbiomonito
Page 18 and 19: The future: The EU Pilot ProjectESB
Page 20 and 21: 2 Main types of HBM activities- SUR
Page 22 and 23: wo protocolsASilicacolumnHexane/DEE
Page 24 and 25: Breast milk monitoringblicationCoun
Page 26 and 27: HBM in FlandersFlanders(1998)EU(199
Page 28 and 29: Effect of gender:Marker PCBs (ng/ g
Page 30 and 31: Determinants of CALUX TEQin adolesc
Page 32 and 33: Correlation between CaluxTEQ and to
Page 34 and 35: Study areas:8 study areas in Flande
Page 36 and 37: FLEHS: newborns cord blood (2002-20
Page 38 and 39: HBM in Flanders• Some results-Ris
Page 40 and 41: PitfallsComparison between differen

HumanBioMonitoring-Schoeters - BioDetection Systems

Create successful ePaper yourself

Delete template?

Save as template?